Developing pharmacological therapies for Alzheimer disease

ISSN： 1420-682X

Source： Cellular and Molecular Life Sciences CMLS, Vol.64, Iss.17, 2007-09, pp. : 2234-2244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease

By Hamaguchi T. Ono K. Yamada M.

Cellular and Molecular Life Sciences CMLS, Vol. 63, Iss. 13, 2006-07 ,pp. : 1538-1552

Springer Publishing Company

Access to resources Recommend Favorite

Potential of neural stem cell‐based therapies for Alzheimer's disease

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 9, 2015-09 ,pp. : 1313-1324

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mitochondrial Drugs for Alzheimer Disease

By Bonda David J. Wang Xinglong Gustaw-Rothenberg Katarzyna A. Perry George Smith Mark A. Zhu Xiongwei

Pharmaceuticals, Vol. 2, Iss. 3, 2009-12 ,pp. : 287-298

MDPI

Access to resources Recommend Favorite

Melatonin in Alzheimer’s Disease

By Lin Li Huang Qiong-Xia Yang Shu-Sheng Chu Jiang Wang Jian-Zhi Tian Qing

International Journal of Molecular Sciences, Vol. 14, Iss. 7, 2013-07 ,pp. : 14575-14593

MDPI

Access to resources Recommend Favorite

Noncoding RNAs in Alzheimer's disease

WILEY INTERDISCIPLINARY REVIEWS: RNA (ELECTRONIC), Vol. 9, Iss. 2, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite